Authors/Disclosures
|
Mohammed Aldosari, MD, ABP, ABPN
(Cleveland Clinic Foundation)
|
No disclosure on file |
|
Mohammad A. Al-Muhaizea, MD
(KFSH&RC- Dept. Neurosciences (MBC 76))
|
Dr. Al-Muhaizea has nothing to disclose. |
|
Ahood M. Almuslamani
|
No disclosure on file |
|
Jesse Dawson
|
Jesse Dawson, 12284 has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Jesse Dawson, 12284 has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Jesse Dawson, 12284 has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Jesse Dawson, 12284 has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Jesse Dawson, 12284 has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boeringher Ingelheim. Jesse Dawson, 12284 has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. |
|
Aziza Chedrawi, MD
|
No disclosure on file |
|
Hesham M. Al-Dhalaan, MD
(Kfshrc)
|
No disclosure on file |
|
Erik K. St. Louis, MD
(Mayo Clinic)
|
The institution of Dr. St. Louis has received research support from NIH. Dr. St. Louis has received publishing royalties from a publication relating to health care. Dr. St. Louis has received publishing royalties from a publication relating to health care. |